Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Kidney Transplantation

Free Subscription Articles published in J Am Soc Nephrol Retrieve available abstracts of 48 articles: HTML format

Single Articles

December 2025
1. CHAPMAN GB, Dhaun N
   Cardiovascular Risk Assessment in Kidney Transplantation: Are We Asking the Right Questions?
   J Am Soc Nephrol. 2025 Dec 23. doi: 10.1681/ASN.0000000987.
   PubMed    
   
   
   
2. CHEN G, Wang Z
   Conceptual and Methodological Considerations in Assessing Disparities after Preemptive Kidney Transplant Waitlisting.
   J Am Soc Nephrol. 2025 Dec 16. doi: 10.1681/ASN.0000000973.
   PubMed    
   
   
   
3. ADEYEMO S, Crews DC, Lentine KL, Al Ammary F, et al
   Authors' Reply: Conceptual and Methodological Considerations in Assessing Disparities after Preemptive Kidney Transplant Waitlisting.
   J Am Soc Nephrol. 2025 Dec 16. doi: 10.1681/ASN.0000000974.
   PubMed    
   
   
   
4. HUSAIN SA, Neil D, Sharif A, Naesens M, et al
   Preimplantation Histopathologic Assessment of Deceased Donor Kidneys: Recommendations from the Banff Time-Zero Biopsy Working Group.
   J Am Soc Nephrol. 2025;36:2505-2513.
   PubMed     Abstract available
   
   
   November 2025
5. BRENNAN DC
   Redefining Immunosuppression in Older Kidney Transplant Recipients: Reflections on the OPTIMIZE Study.
   J Am Soc Nephrol. 2025 Nov 7. doi: 10.1681/ASN.0000000939.
   PubMed    
   
   
   
6. SANDERS JF, de Boer SE, Jonker J, Bemelman FJ, et al
   Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled Trial.
   J Am Soc Nephrol. 2025 Nov 7. doi: 10.1681/ASN.0000000924.
   PubMed    
   
   
   
7. CARDOSO DE AGUIAR R, Willicombe M, Roufosse C
   Noninvasive Diagnosis of Kidney Allograft Rejection.
   J Am Soc Nephrol. 2025;36:2269-2285.
   PubMed     Abstract available
   
   
   October 2025
8. TATAPUDI VS, Mattoo A, Schiff T, Mehta SA, et al
   Xenotransplantation: Current Understanding of the Mechanism of Immune-Mediated Injury.
   J Am Soc Nephrol. 2025;36:2030-2040.
   PubMed     Abstract available
   
   
   September 2025
9. ADEYEMO S, Crews DC, Lentine KL, Zisman-Ilani Y, et al
   Racial and Ethnic Disparities in Outcomes following Preemptive Kidney Transplant Waitlisting in the United States from 2009-2024.
   J Am Soc Nephrol. 2025 Sep 16. doi: 10.1681/ASN.0000000876.
   PubMed     Abstract available
   
   
   
10. EBRAHIMI N, Wongworawat YC, Pour AA, Norouzi S, et al
    Correction to: Kidney Week 2024 Abstract Treatment of Recurrent IgA Nephropathy after Kidney Transplant with Delayed-Release Budesonide TH-PO709.
    J Am Soc Nephrol. 2025 Sep 10. doi: 10.1681/ASN.0000000892.
    PubMed    
    
    
    July 2025
11. CHRISTOU CD, Jaradat F, Olsburgh J, Sacks S, et al
    Rationale for Targeting Complement to Mitigate Renal Transplant Ischemia-Reperfusion Injury.
    J Am Soc Nephrol. 2025 Jul 22. doi: 10.1681/ASN.0000000826.
    PubMed     Abstract available
    
    
    May 2025
12. PERKINS GB, Tunbridge MJ, Chai CS, Hope CM, et al
    mTOR Inhibitors and Vaccine Response in Kidney Transplant Recipients.
    J Am Soc Nephrol. 2025 May 22. doi: 10.1681/ASN.0000000716.
    PubMed     Abstract available
    
    
    
13. SCHOLD JD, Arrigain S, Husain SA, Yu M, et al
    Variation of eGFR Wait Time Modifications for Black Kidney Transplant Candidates in the United States.
    J Am Soc Nephrol. 2025 May 6. doi: 10.1681/ASN.0000000734.
    PubMed     Abstract available
    
    
    
14. JAVA A, Sparks MA, Kavanagh D
    Post-transplant Thrombotic Microangiopathy.
    J Am Soc Nephrol. 2025;36:940-951.
    PubMed     Abstract available
    
    
    April 2025
15. VINSON AJ, Matas A
    Late Allograft Loss and Contemporary Cardiorenal Metabolic Therapies.
    J Am Soc Nephrol. 2025;36:1659-1667.
    PubMed     Abstract available
    
    
    
16. TRUCHOT A, Raynaud M, Helantera I, Aubert O, et al
    Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure.
    J Am Soc Nephrol. 2025;36:688-701.
    PubMed     Abstract available
    
    
    March 2025
17. TELLEZ GARCIA JM, Steenvoorden T, Bemelman F, Hilhorst M, et al
    The Purinoreceptor P2X7 in Extracellular ATP-Mediated Inflammation through the Spectrum of Kidney Diseases and Kidney Transplantation.
    J Am Soc Nephrol. 2025 Mar 28. doi: 10.1681/ASN.0000000711.
    PubMed     Abstract available
    
    
    February 2025
18. ADLER JT, Kuk AE, Drewry KM, Nguyen KH, et al
    Implications of Increased Medicare Advantage Enrollment for Access to Kidney Transplant Waitlisting.
    J Am Soc Nephrol. 2025 Feb 20. doi: 10.1681/ASN.0000000667.
    PubMed    
    
    
    November 2024
19. TANGIRALA N, Hewawasam E, Davies CE, Poprzeczny A, et al
    Labor and Delivery Outcomes in Australian Mothers after Kidney Transplantation.
    J Am Soc Nephrol. 2024 Nov 25. doi: 10.1681/ASN.0000000559.
    PubMed    
    
    
    October 2024
20. HELLE F, Aubry A, Morel V, Descamps V, et al
    Neutralizing Antibodies Targeting BK Polyomavirus: Clinical Importance and Therapeutic Potential for Kidney Transplant Recipients.
    J Am Soc Nephrol. 2024;35:1425-1433.
    PubMed     Abstract available
    
    
    September 2024
21. WILHELM M, Geng A, Schaub S, Hirsch HH, et al
    Posoleucel for BK Polyomavirus in Kidney Transplant Recipients.
    J Am Soc Nephrol. 2024 Sep 20. doi: 10.1681/ASN.0000000000000500.
    PubMed    
    
    
    
22. KIMMEL PL, Fwu CW, Nolin TD, Schulman IH, et al
    Opioid Prescriptions for US Patients Undergoing Long-Term Dialysis or with Kidney Transplant from 2011 to 2020.
    J Am Soc Nephrol. 2024 Sep 3. doi: 10.1681/ASN.0000000000000478.
    PubMed     Abstract available
    
    
    
23. PERCUDANI R, Capelli C, Sassi G, Mori G, et al
    Evolutionary Differences in Uric Acid Metabolism Inform about the Risks of Pig-to-Human Kidney Transplant.
    J Am Soc Nephrol. 2024;35:1281-1283.
    PubMed    
    
    
    August 2024
24. CHAO CT
    The Role of Malnutrition and Psychiatric Illnesses in Olfactory Dysfunction Post-Kidney Transplantation.
    J Am Soc Nephrol. 2024 Aug 27. doi: 10.1681/ASN.0000000000000482.
    PubMed    
    
    
    
25. GUPTA A
    Authors' Reply: The Role of Malnutrition and Psychiatric Illnesses in Olfactory Dysfunction Post-Kidney Transplantation.
    J Am Soc Nephrol. 2024 Aug 27. doi: 10.1681/ASN.0000000000000483.
    PubMed    
    
    
    
26. MANNON RB, Vincenti F
    Poised for Innovation: Considerations for End Points for New Drug Development in Kidney Transplantation.
    J Am Soc Nephrol. 2024 Aug 5. doi: 10.1681/ASN.0000000000000475.
    PubMed    
    
    
    
27. AL AMMARY F, Adeyemo S, Lentine KL, Muzaale AD, et al
    Evolution of Biologically Related Living Kidney Donation in the United States from 1988 to 2022.
    J Am Soc Nephrol. 2024;35:1104-1106.
    PubMed    
    
    
    
28. KNOERS NVAM, van Eerde AM
    The Role of Genetic Testing in Adult CKD.
    J Am Soc Nephrol. 2024;35:1107-1118.
    PubMed     Abstract available
    
    
    July 2024
29. PAJEWSKI NM, Beddhu S, Bress AP, Chang TI, et al
    The Legacy Effect of Intensive versus Standard Blood Pressure Control on the Incidence of Dialysis or Kidney Transplantation.
    J Am Soc Nephrol. 2024 Jul 30. doi: 10.1681/ASN.0000000000000459.
    PubMed     Abstract available
    
    
    
30. GUPTA A, Holloway P, Young K, Villwock J, et al
    Changes in Olfactory and Cognitive Function after Kidney Transplantation.
    J Am Soc Nephrol. 2024 Jul 9. doi: 10.1681/ASN.0000000000000456.
    PubMed    
    
    
    
31. HELLE F, Aubry A, Morel V, Descamps V, et al
    Neutralizing Antibodies Targeting BK Polyomavirus: Clinical Importance and Therapeutic Potential for Kidney Transplant Recipients.
    J Am Soc Nephrol. 2024 Jul 9. doi: 10.1681/ASN.0000000000000457.
    PubMed     Abstract available
    
    
    
32. PATZER RE
    Bridging Racial Disparities in Access to Kidney Transplantation in the United States: Glass Part-Empty or Part-Full?
    J Am Soc Nephrol. 2024;35:959-961.
    PubMed    
    
    
    May 2024
33. STOCK P, Rickert CG
    Consent for High-Kidney Donor Profile Index Kidneys: The Responsibility of Transplant Centers to Get it Right.
    J Am Soc Nephrol. 2024;35:528-529.
    PubMed    
    
    
    
34. SCHOLD JD, Conzen KD, Cooper J, Arrigain S, et al
    Quantifying the Effect of Consent for High-Kidney Donor Profile Index Deceased Donor Transplants in the United States.
    J Am Soc Nephrol. 2024;35:630-641.
    PubMed    
    
    
    
35. KING KL, Yu M, Huml AM, Schold JD, et al
    Allocation and Utilization Patterns of Deceased Donor Kidneys for Preemptive Transplantation in the United States.
    J Am Soc Nephrol. 2024;35:642-645.
    PubMed    
    
    
    April 2024
36. VAULET T, Callemeyn J, Lamarthee B, Antoranz A, et al
    The Clinical Relevance of the Infiltrating Immune Cell Composition in Kidney Transplant Rejection.
    J Am Soc Nephrol. 2024 Apr 19. doi: 10.1681/ASN.0000000000000350.
    PubMed     Abstract available
    
    
    
37. STEINER RW
    Equity in Preemptive Kidney Transplantation: The Case for Caution.
    J Am Soc Nephrol. 2024 Apr 8. doi: 10.1681/ASN.0000000000000347.
    PubMed    
    
    
    March 2024
38. CHANDRAKER A, Regmi A, Gohh R, Sharma A, et al
    Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
    J Am Soc Nephrol. 2024 Mar 12. doi: 10.1681/ASN.0000000000000329.
    PubMed     Abstract available
    
    
    
39. LAN JH
    Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape.
    J Am Soc Nephrol. 2024;35:259-260.
    PubMed    
    
    
    January 2024
40. ADLER JT, Kuk AE, Cron DC, Parast L, et al
    Insurance Transitions from Employer-Based Insurance to Medicare and Waitlisting for Kidney Transplantation: Placing Marietta v. DaVita in Context.
    J Am Soc Nephrol. 2024 Jan 15. doi: 10.1681/ASN.0000000000000298.
    PubMed    
    
    
    
41. BAE S, McAdams-DeMarco MA
    Authors' Reply: Lipid Management and Interactions with Immunosuppressants in Kidney Transplant Patients: Some Opinions and Prospects.
    J Am Soc Nephrol. 2024;35:130.
    PubMed    
    
    
    
42. LI Y, Luo F, Gao Q, Su L, et al
    Lipid Management and Interactions with Immunosuppressants in Patients Undergoing Kidney Transplant: Opinions and Prospects.
    J Am Soc Nephrol. 2024;35:129.
    PubMed    
    
    
    December 2023
43. VINCENTI F, Bestard O, Brar A, Cruzado JM, et al
    Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant.
    J Am Soc Nephrol. 2023 Dec 26. doi: 10.1681/ASN.0000000000000287.
    PubMed     Abstract available
    
    
    
44. HUSAIN SA
    Recentering Accountability for Disparities in Kidney Transplant Access.
    J Am Soc Nephrol. 2023 Dec 12. doi: 10.1681/ASN.0000000000000290.
    PubMed    
    
    
    
45. RAYNAUD M, Al-Awadhi S, Louis K, Zhang H, et al
    Prognostic Biomarkers in Kidney Transplantation: a Systematic Review and Critical Appraisal.
    J Am Soc Nephrol. 2023 Dec 6. doi: 10.1681/ASN.0000000000000260.
    PubMed     Abstract available
    
    
    
46. RIZZOLO K, Cervantes L, Wilhalme H, Vasilyev A, et al
    Differences in Outcomes by Place of Origin among Hispanic Patients with Kidney Failure.
    J Am Soc Nephrol. 2023;34:2013-2023.
    PubMed     Abstract available
    
    
    October 2023
47. SCHOLD JD, Huml AM, Husain SA, Mohan S, et al
    Why the National Academies Got it Wrong about Changing Preemptive Listing Priority for Kidney Transplantation.
    J Am Soc Nephrol. 2023;34:1615-1617.
    PubMed    
    
    
    
48. GREGORY AV, Denic A, Moustafa A, Dasaraju PG, et al
    The Number and Size of Individual Kidney Medullary Pyramids is Associated with Clinical Characteristics, Kidney Biopsy Findings, and CKD Outcomes among Kidney Donors.
    J Am Soc Nephrol. 2023;34:1752-1763.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Kidney Transplantation is free of charge.